Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGNITE: IV Gallium Nitrate in Cystic Fibrosis
NCT02354859Phase 2Completed
- Sponsor
- University of Washington
- Start
- Mar 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Gallium Nitrate with Placebo (2 arms). Primary endpoint: Number of Participants With 5% or Greater Relative Change in FEV1 (Liters) From Baseline to Day 28. Started Mar 2016; status: completed.
02
Drugs
gallium nitrate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02354859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354859.